GABA metabolism and transport: effects on synaptic efficacy
Fabian C Roth1, Andreas Draguhn
1Institute of Physiology and Pathophysiology, University of Heidelberg, 69120 Heidelberg, Germany.
Neural Plasticity
|April 25, 2012
Summary
This review explores how the amount of GABA available for release from interneurons is regulated. Understanding presynaptic GABA content is key to controlling neuronal network activity and stability.
Area of Science:
- Neuroscience
- Cellular Neuroscience
- Synaptic Plasticity
Background:
- GABAergic inhibition is crucial for regulating neuronal network excitability and spatiotemporal activity patterns.
- Stable network states depend on the precise timing and amount of GABA release from interneurons.
- Homeostatic regulation of GABA release involves pre- and postsynaptic mechanisms responding to activity-dependent signals.
Purpose of the Study:
- To review findings on the availability of GABA for release at presynaptic terminals of interneurons.
- To discuss how presynaptic GABA content influences inhibitory efficacy and neuronal network patterns.
- To explore pharmacological strategies targeting GABAergic regulation.
Main Methods:
- Literature review of studies on GABA synthesis, transport, and degradation.
- Analysis of mechanisms regulating presynaptic GABA availability.
- Discussion of functional impacts on neuronal network dynamics.
Main Results:
- Presynaptic GABA content is a critical determinant of inhibitory efficacy.
- GABA availability can be modulated by regulating GABA synthesis, transport, and degradation.
- Activity-dependent signals trigger homeostatic adjustments in GABA release.
Conclusions:
- Regulation of presynaptic GABA content is a key homeostatic mechanism in neuronal networks.
- Modulating GABA availability offers potential for therapeutic interventions in neurological disorders.
- Understanding these processes is vital for controlling network activity and stability.
Related Concept Videos
01:18Antiepileptic Drugs: GABAergic Pathway Potentiators
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...
01:30Ligand-Gated Ion Channel Receptor: Gating Mechanism
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
01:29Excitatory and Inhibitory Effects of Neurotransmitters
When an action potential reaches the presynaptic axon terminal, it releases neurotransmitters from the neuron into the synaptic cleft at a chemical synapse. The released neurotransmitter can be excitatory or inhibitory. The critical criteria commonly used to determine whether a molecule is a neurotransmitter at a chemical synapse are the molecule's presence in the presynaptic neuron. Second, its release is in response to strong presynaptic depolarization. And lastly, the presence of specific...
01:26Neurochemical Transmission: Sites of Drug Action
Neurochemical transmission, the conduction of electrical impulses between neurons mediated by neurotransmitters, plays a vital role in various physiological processes. Autonomic drugs exert their effects by modulating neurotransmission within the autonomic nervous system. For instance, drugs such as hemicholinium block the precursor uptake necessary for synthesizing acetylcholine, an essential autonomic neurotransmitter. Following synthesis, neurotransmitters are stored in vesicles. Metyrosine...
01:20Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
01:26Chemical Synapses
Chemical synapses are specialized sites between two neurons or between a neuron and a non-neuronal cell like a muscle, glandular or sensory cell.
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...